RMD 1.41% $14.00 resmed inc

RMD - A possible profit clue

  1. 406 Posts.
    Respironics ( RESP - NASDAQ ) has just reported the last Q results . Part of RESPIRONICS biz is actually the second leg in the DUOPOLY of RMD/RESP in the APNEA sleep disorder market . Key drivers for the Company's domestic revenue performance include a year-over-year increase of 15 percent in domestic sleep therapy products. Let's hope RMD did the same . First call consensus expected increase for RMD is 12% in EPS growth .It is expected to report EPS USc 28 for the Q and USD 1.06 for the FY , Duff
 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
(20min delay)
Last
$14.00
Change
-0.20(1.41%)
Mkt cap $20.23B
Open High Low Value Volume
$14.02 $14.06 $13.94 $25.71M 1.839M

Buyers (Bids)

No. Vol. Price($)
2 26000 $13.99
 

Sellers (Offers)

Price($) Vol. No.
$14.01 7168 1
Last update - 16.10pm 20/11/2018 (20 minute delay) ?
(live)
Last
$13.95
  Change
-0.20 ( 1.76 %)
Open High   Low Volume
$14.06 $14.06   $13.94 280186
Last updated 15.59pm 20/11/2018 (live) ?
RMD (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.